Market Overview:
The global EEG, EMG and evoked potential devices market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of neurological disorders, rising geriatric population, and technological advancements in EEG, EMG, and evoked potential devices. This large share can be attributed to the increasing prevalence of neurological disorders such as epilepsy and Alzheimer’s disease that require diagnosis through EEG testing. Based on application, the global EEG, EMG.
Product Definition:
This activity can be used to help diagnose problems with your brain, such as seizures.
EMG- Electromyography is a test that measures the electrical activity of your muscles. This activity can be used to help diagnose problems with your muscles, such as weakness or damage.
EP- Evoked potentials are tests that measure the electrical signals in your brain and spinal cord in response to certain stimuli, such as sound or touch. These tests can be used to help diagnose problems with your nervous system, such as nerve damage.
Electroencephalography (EEG):
It helps in diagnosing and classifying neurological disorders, such as epilepsy, Alzheimer's disease, Parkinson’s disease and stroke. EEG is an invasive medical device used for recording electrical activities of the brain through electrodes placed on scalp. The device works by detecting abnormal activities in certain parts of the brain due to which it has gained popularity among neurologists all over the world.
Electromyography (EMG) and Evoked Potential Devices:
Electromyography (EMG) and evoked potential devices are used for measuring the electrical activity of muscles.It is a diagnostic procedure that helps in analyzing muscle strength and identifying possible injuries or diseases related to the myoelectric system. EMG also provides valuable information with respect to rehabilitation of patients suffering from neuromuscular disorders such as muscular dystrophies,myasthenia gravis,bradycardias etc.
Application Insights:
The others segment dominated the global market in 2017, accounting for 33.3% share of the overall revenue. The other applications include research institutes and home healthcare settings. In recent years, there has been a rise in demand for brain activity tests to diagnose neurological conditions in adults as well as pediatric patients. For instance, according to a study published by NCBI in 2018, it is estimated that around 300 million people worldwide have some form of epilepsy and 50 million are diagnosed with epilepsy every year making it one of the most common neurological diseases across the world along with Alzheimer¢â‚¬â„¢s disease and Parkinson¢â‚¬â„¢s disease which involvesEEG testing for diagnosis purpose. Therefore, increasing awareness about these disorders coupled with technological advancements is expected to drive growth over next few years globally thereby contributing towards market growth across all regions measured thus far.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of well-established healthcare facilities, increasing prevalence of neurological disorders, and availability of advanced products for diagnostic procedures. Moreover, rising government initiatives to create awareness regarding brain related disorders and their treatment options are some other factors driving regional growth. For instance, in 2014 Global Initiative for Epilepsy (GIE) launched a new campaign called “Make it count†which is aimed towards creating awareness about epilepsy care around the world including research activities conducted by individuals with epilepsy as well as their families or friends who have been affected by this condition.
Growth Factors:
- Increasing demand for early diagnosis and treatment of neurological disorders
- Rising prevalence of chronic diseases such as Alzheimer's disease, Parkinson's disease, and epilepsy
- Growing geriatric population
- Technological advancements in EEG, EMG, and evoked potential devices
- Increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
EEG,EMG and Evoked Potential Devices Market Research Report
By Type
Electroencephalography (EEG), Electromyography (EMG) and Evoked Potential Devices
By Application
Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Others
By Companies
Cadwell Laboratories (US), Compumedics (Australia), EB Neuro S.P.A. (Italy), Electrical Geodesics (US), Lifelines Neurodiagnostic Systems (US), Natus Medical (US), NeuroWave Systems (US), Nihon Kohden (Japan), Nihon Kohden America (US), Noraxon (US), Cadwell Laboratories (US)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global EEG,EMG and Evoked Potential Devices Market Report Segments:
The global EEG,EMG and Evoked Potential Devices market is segmented on the basis of:
Types
Electroencephalography (EEG), Electromyography (EMG) and Evoked Potential Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cadwell Laboratories (US)
- Compumedics (Australia)
- EB Neuro S.P.A. (Italy)
- Electrical Geodesics (US)
- Lifelines Neurodiagnostic Systems (US)
- Natus Medical (US)
- NeuroWave Systems (US)
- Nihon Kohden (Japan)
- Nihon Kohden America (US)
- Noraxon (US)
- Cadwell Laboratories (US)
Highlights of The EEG,EMG and Evoked Potential Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Electroencephalography (EEG)
- Electromyography (EMG) and Evoked Potential Devices
- By Application:
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Specialty Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the EEG,EMG and Evoked Potential Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
EEG, EMG and Evoked Potential Devices measure electrical activity in the brain. EEG measures the electrical activity of the brain waves while EMG measures muscle movement. Evoked potential devices measure changes in blood pressure, heart rate and other bodily functions that are related to emotional response.
Some of the major companies in the eeg,emg and evoked potential devices market are Cadwell Laboratories (US), Compumedics (Australia), EB Neuro S.P.A. (Italy), Electrical Geodesics (US), Lifelines Neurodiagnostic Systems (US), Natus Medical (US), NeuroWave Systems (US), Nihon Kohden (Japan), Nihon Kohden America (US), Noraxon (US), Cadwell Laboratories (US).
The eeg,emg and evoked potential devices market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 EEG,EMG and Evoked Potential Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 EEG,EMG and Evoked Potential Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 EEG,EMG and Evoked Potential Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the EEG,EMG and Evoked Potential Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global EEG,EMG and Evoked Potential Devices Market Size & Forecast, 2020-2028
4.5.1 EEG,EMG and Evoked Potential Devices Market Size and Y-o-Y Growth
4.5.2 EEG,EMG and Evoked Potential Devices Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Electroencephalography (EEG)
5.2.2 Electromyography (EMG) and Evoked Potential Devices
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers (ASCs)
6.2.3 Specialty Clinics
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global EEG,EMG and Evoked Potential Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 EEG,EMG and Evoked Potential Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Electroencephalography (EEG)
9.6.2 Electromyography (EMG) and Evoked Potential Devices
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers (ASCs)
9.10.3 Specialty Clinics
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Electroencephalography (EEG)
10.6.2 Electromyography (EMG) and Evoked Potential Devices
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers (ASCs)
10.10.3 Specialty Clinics
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Electroencephalography (EEG)
11.6.2 Electromyography (EMG) and Evoked Potential Devices
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers (ASCs)
11.10.3 Specialty Clinics
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Electroencephalography (EEG)
12.6.2 Electromyography (EMG) and Evoked Potential Devices
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers (ASCs)
12.10.3 Specialty Clinics
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Electroencephalography (EEG)
13.6.2 Electromyography (EMG) and Evoked Potential Devices
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers (ASCs)
13.10.3 Specialty Clinics
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 EEG,EMG and Evoked Potential Devices Market: Competitive Dashboard
14.2 Global EEG,EMG and Evoked Potential Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cadwell Laboratories (US)
14.3.2 Compumedics (Australia)
14.3.3 EB Neuro S.P.A. (Italy)
14.3.4 Electrical Geodesics (US)
14.3.5 Lifelines Neurodiagnostic Systems (US)
14.3.6 Natus Medical (US)
14.3.7 NeuroWave Systems (US)
14.3.8 Nihon Kohden (Japan)
14.3.9 Nihon Kohden America (US)
14.3.10 Noraxon (US)
14.3.11 Cadwell Laboratories (US)
